What Is Healthcare's Most Important Medical Instrument? Not What You Think. Pioneer Health Care Organizations Share Lessons Learned and Challenges Ahead. Hospital Association "Declares War" on Patient Empowerment. Health Systems Ignore Patients at Their Own Peril. “The most important member of the care team is the patient.” That has been a statement one has heard in healthcare for decades, yet it has never been more important. Why? It is next to impossible to succeed in the value and outcome-based healthcare reimbursement model every private and government payor is driving towards (with or without Obamacare). In my experience reviewing or implementing over 100 health IT systems, the core purpose of legacy healthIT systems is crystal clear — their job is to get as big a bill out as quickly as possible.
Why wouldn’t it? While there is great ambiguity about the future of healthcare, there is one certainty: healthcare will be paid based on some blend of value/quality/outcome and a shifting away from the “do more, bill more” reimbursement model. Who is in control of decisions driving outcomes. The graphic above speaks to the importance of the individual (or family) in the care process. IBM's Reinvention Should Inspire Flat Pharma Businesses. Patients Are More Than A Vessel For Billing Codes. Editor’s note: This guest post was written by Dave Chase, the CEO of Avado.com, a patient portal & relationship management company that was a TechCrunch Disrupt finalist. Previously he was a management consultant for Accenture’s healthcare practice and founder of Microsoft’s Health platform business. You can follow him on Twitter @chasedave. It will be virtually impossible to succeed in the new reimbursement model without recognizing what has long been said, but little done about it — “the most important member of the care team is the patient.”
Having implemented or reviewed over 100 health IT systems, there is one common purpose at the core of the architecture of these systems — how to get as big a bill out as quickly as possible. That has been an entirely rational response to the flawed reimbursement model at the heart of healthcare’s hyperinflation (here’s a not-so-fun fact: Since the ’60s, while all non-healthcare expenditures increased 8x, healthcare increased 274x). Healthcare's Medical Instrument of the Future: Communication. Eric Dishman: Take health care off the mainframe. Www.avado.com/whitepapers/Patient-centric-website.pdf. Direct primary care and the Marcus Welby vision of primary care.
The insurance middleman has taken a toll on the family doctor. New practice models plan to change that. Physicians in Seattle, Silicon Valley and Boston are proving what the rest of the world already knows. When you have a high function primary care system, there’s less money spent and better health outcomes. Before House, M.D., there was Marcus Welby, M.D. who epitomized the glory days of healthcare. Dr. Welby knew every one of his patients. If you got sick, he took care of you right away, always spending whatever time necessary.
Unfortunately, there’s a radically differently model today that can only be described as a Gordian Knot designed by Rube Goldberg. Consider the following scenario: It can take a patient days to get in for an appointment, they arrive for an appointment, wait 45 minutes in the crowded waiting room, wait again in the exam room, and then get 10 minutes with their doctor, 15 if they’re lucky. Click to enlarge Benjamin Franklin was right. How it works. Why It’s Good News HealthIT is So Bad. Editor’s note: This guest post was written by Dave Chase, the CEO of Avado.com, a patient portal & relationship management company that was a TechCrunch Disrupt finalist. Previously he was a management consultant for Accenture’s healthcare practice and founder of Microsoft’s Health platform business. You can follow him on Twitter @chasedave.
Image is courtesy of Wikimedia Commons. I know of no industry where technology is as despised as it is in healthcare. It’s telling that it took government money to incentivize healthcare providers to finally do what virtually every other industry has done — apply information technology to streamline processes. While one might dismiss this coming from a company with a dog in the fight, the feeling is nearly universal amongst doctors who are the most important users (besides patients who are almost completely ignored).
More recently, there’s been a drive to add so-called Patient Portals to involve the patient. The Good News. The Most Important Organization In Silicon Valley That No One Has Heard About. Editor’s note: This guest post was written by Dave Chase, the CEO of Avado.com, a health technology company that was a TechCrunch Disrupt finalist. Previously he was a management consultant for Accenture’s healthcare practice and was the founder of Microsoft’s Health business. You can follow him on Twitter @chasedave. Imagine something so insidious that it leads to the following: over 750,000 personal bankruptcies per year. In Bill Gates’ recent TED talk, he described it as the factor that is devastating education budgets and is leading to a pitting of old versus young; it impairs U.S.
-based automakers by adding a $2000 “tax” on all of their vehicles; many believe it is the primary driver of the jobless recovery. What is it? From the time Dr. It is a relatively recent phenomenon to have day-to-day medicine paid for through insurance. Fortunately, pioneers such as Dr. MedLion recently opened up a clinic in Mountain View, California in the heart of Silicon Valley. Many view what Dr. Dr. The Rise of Nimble Medicine. Editor’s note: This guest post was written by Dave Chase, the CEO of Avado.com, a patient portal & relationship management company that was a TechCrunch Disrupt finalist.
Previously he was a management consultant for Accenture’s healthcare practice and founder of Microsoft’s Health platform business. You can follow him on Twitter @chasedave. Images are courtesy of Jason Hwang, M.D., M.B.A. Executive Director, Healthcare of the Innosight Institute and co-author of The Innovator’s Prescription. In the New Yorker, Dr. Atul Gawande outlined how, at the turn of the 20th century, more than forty per cent of household income went to paying for food and food production consumed nearly half the workforce. Traditionally, attempting a new care or payment model meant long planning and development cycles. In their book, The Innovator’s Prescription, Clayton Christensen and Dr. Related articles: Money Ball for Medicine – Business Models for Healthcare. Money Ball for Medicine – Business Models for Healthcare.
Editor’s note: This guest post was written by Dave Chase, the CEO of Avado.com, a patient portal & relationship management company that was a TechCrunch Disrupt finalist. Previously he was a management consultant for Accenture’s healthcare practice and founder of Microsoft’s Health platform business. You can follow him on Twitter@chasedave. Entrepreneurial epiphanies surface in random places. For Eric Page, it was watching Brad Pitt’s latest movie, Moneyball.
The epiphany caused him to shift Amplify Health’s business model from a provider of technology to a heavy user of technology. While there is a wave of disruptive technology in healthtech, as interesting is the wave of disruptive innovation on the care delivery side of healthcare. Previously, Page had been the Founder & President of REM Medical, a clinic for sufferers of sleep apnea. With the success of his previous company, Page thought it would be easy to sell this vision to healthcare providers. Nimble Medicine. By Dave Chase In a piece for the New Yorker, Dr. Atul Gawande outlined how, early in the 1900s, more than forty per cent of household income went to paying for food and food production consumed roughly half the workforce. Beginning in Texas, a wide array of new methods of food production were tested. After many pilots, tests and information dissemination, food now accounts for 8% of household budgets and 2% of the workforce. As a wide array of small innovations ultimately led to the transformation of farming, so too is a rapidly building wave of innovative new care and payment models leading to similar breakthroughs in healthcare.
I call this Nimble Medicine. Until recently, attempting a new care or payment model meant long planning and development cycles. In their book, The Innovator’s Prescription, Clayton Christensen and Dr. In contrast, disruptive innovators such as Qliance and WhiteGlove Health rethought the care delivery and payment models from the ground up. Avado Launches ‘Patient Relationship Management’ Platform To Help Healthcare Providers Go Digital. Back in May, Avado was chosen as a finalist at TechCrunch Disrupt in NYC. The startup’s ambition was, said in reductive terms, to become the Salesforce.com of personal health records. (You can read our initial coverage here.) In other words, like Salesforce’s “customer relationship management” (CRM), Avado is building a “patient relationship management” (PRM) platform in an attempt to create a more fluid and communicative relationship between patients and doctors — by way of connected health records.
The future of medical practice, Avado CEO Dave Chase says, is very clear: “It’s about being accountable and patient-centric”. Since Disrupt, Avado has been working on building out that robust (and freemium-modeled) communication platform for care providers and their patients, and, today, Avado is officially coming out of beta to launch its service to the public. As to how Avado is working for businesses, Dr. For more on Avado, check them out at home here. Healthcare Disruption: Pharma 3.0 Will Drive Shift from Life Science to HealthTech Investing (Part I of III)
Editor’s note: This guest post was written by Dave Chase, the CEO of Avado.com, a health technology company that was a TechCrunch Disrupt finalist. Previously he was a management consultant for Accenture’s healthcare practice and was the founder of Microsoft’s Health business. You can follow him on Twitter @chasedave. Healthcare’s hyperinflation is driving the transformation of how care gets reimbursed resulting in a massive disruption in healthcare.
For example, pharma companies will succeed or fail based not on how much drug they sell, but on how well their market offerings improve outcomes. As the largest spenders on R&D in healthcare, massive changes in the way pharmaceutical companies operate are going to have a profound effect on health technology while letting pharma adapt to marketplace changes. In the past, I have frequently said that healthcare is where tech startups go to die. Pharma 3.0 Will Drive Shift from Life Science to HealthTech Investing. Dave Chase, Avado CEO, presents to CHC. Healthcare Disruption: Providers Will Use HealthTech to Differentiate and Produce Better Outcomes (Part II) Editor’s note: This guest post was written by Dave Chase, the CEO of Avado.com, a health technology company that was a TechCrunch Disrupt finalist.
Previously he was a management consultant for Accenture’s healthcare practice and was the founder of Microsoft’s Health business. You can follow him on Twitter @chasedave. Historically, in the U.S. Healthcare system, a primary way to differentiate oneself as a healthcare provider has been to have impressive physical assets such as newly built clinics/hospitals/wings and medical equipment. This is logical when the legacy reimbursement model has incentivized activity (procedures, tests, prescriptions) instead of positive health outcomes. However, the DIY Health Reform movement has recognized the flawed fee-for-service reimbursement model has been responsible for healthcare’s hyperinflation. Of course, it needs to go beyond aesthetically pleasing websites. A pharma executive explained to me the need to focus more on health technology. Healthcare Disruption: Providers Are Making Newspaper Industry Mistakes (Part III) Editor’s note: This guest post was written by Dave Chase, the CEO of Avado.com, a health technology company that was a TechCrunch Disrupt finalist.
Previously he was a management consultant for Accenture’s healthcare practice consulting to 25 hospitals and was the founder of Microsoft’s Health business. You can follow him on Twitter @chasedave. Since the latter half of the 90’s, the handwriting has been on the wall for newspaper companies that media’s future was digital. Heck, the newspapers’ own business sections reported on this trend. Despite this, the majority of the industry focused on traditional strategies such as taking on debt to acquire other newspapers or investing in new printing presses, leading to disastrous consequences. To be fair, there were some digital investments made, including hiring top-drawer talent. Now consider healthcare in the U.S.: There’s a clear understanding that the industry must shift its focus towards outcomes from “do more, bill more” orientation. Dr. Www.medicalhomeinfo.org/downloads/pdfs/jointstatement.pdf.
Lessons from the Carnage in HealthTech. By DAVE CHASE Recently ZocDoc had a huge funding round demonstrating the success that they are having. There’s a number of lessons learned from ZocDoc’s experience. Unfortunately, many haven’t demonstrated Zocdoc’s wisdom leading to a large number of healthtech failures. A recent study highlights this phenomena.
After interviewing 110 digital health entrepreneurs, RockHealth recently released its study Rock Report: State of Digital Health demonstrating the disconnect between the startups getting funding and what many startups are pursuing. This disconnect is the last and most important reason healthtech companies have failed that are detailed below. Lack of Specific Focus or Adoption point It’s well documented that a lack of focus kills startups whether they are in healthcare or not but it is particularly prevalent in healthcare. Expected consumers to pay With the exception of weight loss programs, there aren’t many examples of consumers paying directly for health services. What Pharma Can Learn From the Railroads and IBM. Editor’s note: This guest post was written by Dave Chase, the CEO of Avado.com, a patient portal & relationship management company that was a TechCrunch Disrupt finalist.
Previously he was a management consultant for Accenture’s healthcare practice and founder of Microsoft’s Health platform business. You can follow him on Twitter @chasedave. Pharmaceutical companies are in trouble with ongoing patent cliffs with a clear choice facing them. They can follow the path of the railroad industry which is the path most are on right now. Alternatively, they can follow the path IBM took when its future was similarly bleak. The marketing myopia of the railroad industry is well documented in the world of business yet industry after industry makes the same mistake. Pfizer 10 year stock chart The Key Question Pharma Must Answer Does the pharmaceutical company see themselves in the drug business or the disease management business?